Clinical Features of Patients With Primary Angioedema With Normal Levels of C1-Inhibitor - 05/02/19
Doi : 10.1016/j.jaci.2018.12.143
Francesca Perego, MD, PhD 1, Anna Valerieva, MD 2, Chiara Pomaranzi 3, Andrea Zanichelli 4, Maddalena A. Wu, MD 5, Antonio Gidaro, MD 6, Laura Adelaide Dalla Vecchia 7, Marco Cicardi 8
1 IRCCS Istituti Clinici Scientifici Maugeri, Milano, Italy
2 Medical University of Sofia, Sofia, Bulgaria
3 Department of Biomedical and Clinical Sciences “Luigi Sacco”, University of Milan, Milan, Italy
4 Department of Biomedical and Clinical Sciences, ASST Fatebenefratelli Sacco, University of Milan, Luigi Sacco Hospital, Milan, Italy, Milano, italy
5 Department of Biomedical and Clinical Sciences "Luigi Sacco", ASST Fatebenefratelli Sacco, University of Milan, Luigi Sacco Hospital, Milan, Italy, Milan, italy
6 Department of Biomedical and Clinical Sciences, ASST Fatebenefratelli-Sacco, University of Milan, Luigi Sacco Hospital, Milan, Italy., Milano, italy
7 IRCCS Istituti Clinici Scientifici Maugeri, Milan, Italy
8 Department of Biomedical and Clinical Sciences “Luigi Sacco”, University of Milan, ASST Fatebenefratelli Sacco, Milan, Italy
141
Le texte complet de cet article est disponible en PDF.Plan
© 2018
Publié par Elsevier Masson SAS.
Vol 143 - N° 2S
P. AB47 - février 2019 Retour au numéro
Article précédent
- Impact of C1-INH(SC) on Type I/II Hereditary Angioedema: Findings from a US Patient Survey
- Raffi Tachdjian, Mahdi Taqi, Daniel Riley, Girishanthy Krishnarajah
- The French Side of the Global Angioedema Registry
- Isabelle Boccon-Gibod, Maddalena A. Wu, Ruggero Di Maulo, Marta De Munari, Anne Pagnier, Catherine Mansard, Alban Deroux, Mélanie Arnaud, Nelly Carrat, Marco Cicardi, Laurence Bouillet
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?